Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
18-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
18-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #32251
advertisement
Li X
19
Showing records 1 to 19 |
Display all abstracts from
Li X
70116
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Sun Y
BMC Ophthalmology
2016; 16: 150
69777
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Zöller B
Journal of thrombosis and thrombolysis
2016; 42: 505-512
70396
Optic cup segmentation from fundus images for glaucoma diagnosis
Hu M
Bioengineered
2017; 8: 21-28
69833
Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Li X
Journal of Glaucoma
2016; 25: e855-e860
70116
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Liang Y
BMC Ophthalmology
2016; 16: 150
69777
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Li X
Journal of thrombosis and thrombolysis
2016; 42: 505-512
69833
Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Mukkamala L
Journal of Glaucoma
2016; 25: e855-e860
70396
Optic cup segmentation from fundus images for glaucoma diagnosis
Zhu C
Bioengineered
2017; 8: 21-28
69833
Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Origlieri CA
Journal of Glaucoma
2016; 25: e855-e860
70396
Optic cup segmentation from fundus images for glaucoma diagnosis
Li X
Bioengineered
2017; 8: 21-28
70116
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Zhou P
BMC Ophthalmology
2016; 16: 150
69777
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Sundquist J
Journal of thrombosis and thrombolysis
2016; 42: 505-512
70396
Optic cup segmentation from fundus images for glaucoma diagnosis
Xu Y
Bioengineered
2017; 8: 21-28
70116
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Wu H
BMC Ophthalmology
2016; 16: 150
69777
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Sundquist K
Journal of thrombosis and thrombolysis
2016; 42: 505-512
69833
Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Holland BK; Fechtner RD
Journal of Glaucoma
2016; 25: e855-e860
70116
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Hou X
BMC Ophthalmology
2016; 16: 150
69833
Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Khouri AS
Journal of Glaucoma
2016; 25: e855-e860
70116
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Ren Z; Li X; Zhao M
BMC Ophthalmology
2016; 16: 150
Issue
18-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept